O Keefe Stevens Advisory Inc. raised its position in Calumet, Inc. (NASDAQ:CLMT – Free Report) by 12.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,817 shares of the oil and gas company’s stock after acquiring an additional 2,903 shares during the quarter. O Keefe Stevens Advisory Inc.’s holdings in Calumet were worth $423,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Caldwell Sutter Capital Inc. grew its position in Calumet by 29.9% in the second quarter. Caldwell Sutter Capital Inc. now owns 19,483 shares of the oil and gas company’s stock valued at $307,000 after acquiring an additional 4,483 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Calumet by 33.5% in the first quarter. Goldman Sachs Group Inc. now owns 465,269 shares of the oil and gas company’s stock valued at $5,900,000 after acquiring an additional 116,777 shares in the last quarter. Adams Asset Advisors LLC grew its position in Calumet by 0.9% in the second quarter. Adams Asset Advisors LLC now owns 5,406,271 shares of the oil and gas company’s stock valued at $85,176,000 after acquiring an additional 49,948 shares in the last quarter. Finally, Wasserstein Debt Opportunities Management L.P. grew its position in Calumet by 3.2% in the second quarter. Wasserstein Debt Opportunities Management L.P. now owns 5,817,012 shares of the oil and gas company’s stock valued at $91,647,000 after acquiring an additional 180,197 shares in the last quarter. Institutional investors and hedge funds own 34.41% of the company’s stock.
Calumet Stock Performance
CLMT stock opened at $18.59 on Friday. The stock has a market capitalization of $1.61 billion, a price-to-earnings ratio of -3.56 and a beta of 0.98. Calumet, Inc. has a 1 year low of $7.68 and a 1 year high of $25.29. The stock’s fifty day moving average is $16.55 and its two-hundred day moving average is $14.52.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on CLMT. UBS Group increased their price objective on shares of Calumet from $12.00 to $13.25 and gave the company a “neutral” rating in a research report on Tuesday, August 12th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Calumet in a research report on Saturday, September 27th. Four analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $18.71.
View Our Latest Stock Analysis on Calumet
Calumet Profile
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
See Also
- Five stocks we like better than Calumet
- EV Stocks and How to Profit from Them
- Why the Precious Metal Nobody Talks About Could Be Your Best Bet
- Growth Stocks: What They Are, What They Are Not
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Want to see what other hedge funds are holding CLMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calumet, Inc. (NASDAQ:CLMT – Free Report).
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.